Assessment System of Sarcopenia in Lung Cancer Patients
Study on the Value of Musculoskeletal Cross-modal Imaging Assessment System in the Diagnosis and Prognosis of Sarcopenia in Lung Cancer Patients
West China Hospital
1,500 participants
Nov 1, 2023
OBSERVATIONAL
Conditions
Summary
1. To explore the diagnostic value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI for sarcopenia in patients with lung cancer. 2. To explore the value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI in evaluating the prognosis and the effect of nutritional support in patients with lung cancer during perioperative period. 3. To explore the value of musculoskeletal cross-modal imaging assessment system of ultrasound combined with abdominal CT/MRI in evaluating the long-term prognosis of patients with lung cancer.
Eligibility
Inclusion Criteria3
- Hospitalized patients scheduled for radical resection of lung cancer.
- With a CT/MRI examination within 1 week.
- The compliance of examination was good.
Exclusion Criteria4
- Amputated arm or leg.
- Severe oedema (oedema higher than knee level).
- Implantable pacemaker.
- Impaired consciousness, poor general health, or other reasons that would prevent the individual from completing the study.
Interventions
The patients with lung cancer who are scheduled to undergo radical resection of lung cancer are examined by ultrasound at multiple sites of the whole body, including muscle and fat.
The patients with lung cancer who are scheduled to undergo radical resection of lung cancer are examined by abdominal CT/MRI.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06327594